Navigation Links
Generex Biotechnology to Make Presentations At 46th Annual Meeting,of the European Society of Pediatric Endocrinology

WORCESTER, Mass., Jun 27, 2007 (PrimeNewswire via COMTEX News Network) -- Generex Biotechnology Corporation (Nasdaq:GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that it will be making three poster presentations at the 46th Annual Meeting of the European Society of Pediatric Endocrinology in Helsinki, Finland June 27 -- 30, 2007 (www.espe2007.org).


The three abstracts feature Generex Oral-lyn(tm), the Company's proprietary oral insulin spray product, including a study in juveniles. The Company previously announced that it is preparing for a Phase 3 clinical trial of Generex Oral-lyn in centres in the United States, Europe, and Canada. The abstracts are:

6-Month Study on the Safety and Efficacy of Oral Insulin (Generex Oral-lyn(tm)) Administered at Lunchtime in Juvenile Type-1 DM Subjects Maintained on Basal Glargine Insulin and Pre-Breakfast and Pre-Dinner Regular Insulin, by Doctors Jaime Guevara-Aguirre, Marco Guevara-Aguirre, and Jeannette Saavedra, all of the Institute of Endocrinology IEMYR, Quito, Ecuador, together with Dr. Gerald Bernstein, the Company's Vice-President for Medical Affairs;

Comparison Of Metabolic Control Of Pre-Prandial S.C. Regular Insulin Versus Prandia Oral Insulin (Generex Oral-lyn(tm)) In Adult Type-1 DM Subjects Maintained on Basal S.C. BID Isophane Insulin (NPH), by Doctors Jaime Guevara-Aguirre, Marco Guevara-Aguirre, and Jeannette Saavedra, all of the Institute of Endocrinology IEMYR, Quito, Ecuador; and

Near Normalization of Metabolic Control in Type-1 DM Using Conventional Insulin Therapy and a 13-Point Method Designed to Enhance Compliance, by Doctors Jaime Guevara-Aguirre, Marco Guevara-Aguirre, and Jeannette Saavedra, all of the Institute of Endocrinology IEMYR, Quito, Ecuador, together with Dr. Gerald Bernstein,
'"/>




Page: 1 2 3

Related medicine technology :

1. Generex Biotechnology Vaccine Strategy Presented at International Conference in London
2. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
3. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
4. Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease
5. Prana Biotechnology Presents New Key Findings on PBT2
6. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ASCO Annual Meeting
7. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at AUA Annual Meeting
8. Cougar Biotechnology Presents Positive CB7630 Clinical Data at AACR Annual Meeting Late-Breaking Clinical Trials Session
9. Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst Congress of the International Society on Thrombosis and Haemostasis
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
Post Your Comments:
(Date:8/29/2014)... ANGELES , Aug. 29, 2014  Chuma ... both financing alternatives and turnkey support services for ... announce that FINRA processed and approved the Company,s ... 29, 2014, CannaMed Corporation will be known as ... change was accomplished through a merger with the ...
(Date:8/29/2014)... 2014  A Boston Scientific Corporation (NYSE: ... removability and preliminary long term stricture resolution of ... August issue of the peer-reviewed journal, Gastroenterology. ... being conducted in 11 countries and five continents, ... stents (FCSEMS) after extended indwell (i.e., up to ...
(Date:8/29/2014)... 29, 2014 Research and Markets ... Instrument Industry Report, 2014-2017" report to their offering. ... rising proportion of reimbursement for medical expenses, the Chinese ... its scale presenting a CAGR of 19.2% during 2009-2013. ... product segments of orthopedic instruments in China ...
Breaking Medicine Technology:CannaMed Announces Name Change and Trading Symbol Change 2CannaMed Announces Name Change and Trading Symbol Change 3Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 3Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 4China Orthopedic Instrument Industry Report, 2014-2017 2
...  Long research and development cycles.  Low success of clinical ... information technology options.  It,s not just time and money; ... being wasted.   Such justifiable criticisms of ... the formation of a new company, RedOak Logic ...
... hospital patient room of the future is on display – ... that stand to benefit hospitals and patients nationwide. ... in Plainsboro, NJ, to replace its downtown Princeton facility, has ... of the new hospital,s proposed patient room in its existing ...
Cached Medicine Technology:RedOak Logic's Mission: Transform Pharmaceutical Industry Drug Development 2RedOak Logic's Mission: Transform Pharmaceutical Industry Drug Development 3RedOak Logic's Mission: Transform Pharmaceutical Industry Drug Development 4Hospital Room of the Future Debuts in New Jersey 2Hospital Room of the Future Debuts in New Jersey 3Hospital Room of the Future Debuts in New Jersey 4
(Date:9/1/2014)... The B-cell non-Hodgkin’s Lymphoma (NHL) treatment market value ... US, France, Italy, Germany, Spain and the UK), from ... , The competitive landscape in the B-cell NHL markets ... UK is poised to undergo a dramatic shift during ... B-cell NHL indications, which includes Diffuse Large B-Cell Lymphoma ...
(Date:9/1/2014)... As well as having completed the Non ... counselor certification in Louisiana. , "I have ... program as well as the Counselor training program ... and professionally. I am not only dedicated to ... do so. As a Non Violent Crisis Intervention ...
(Date:9/1/2014)... MN (PRWEB) September 01, 2014 In honor of ... on Aug. 22, Animal Emergency & Referral Center of Minnesota (AERC) ... visits a priority for their cats. , Many people don’t take ... too much of a hassle,” but they wouldn’t decide not to ... signs of a cavity. The same goes for pets. Just like ...
(Date:9/1/2014)... Las Vegas, NV (PRWEB) September 01, 2014 ... for entrepreneurs and online marketers that was developed to ... campaign, has caught the attention of Shane Michaels, prompting ... even established entrepreneur, the daily duty of managing all ... online business can be quite overwhelming,” reports Michaels. “That’s ...
(Date:9/1/2014)... 2014 Pastor Thompson is an ordained minister ... Village. He is a licensed minister through the Church of ... twenty years in New Mexico, Colorado and North Dakota. He ... this year. He also has two beautiful daughters, Brianna, ... Pastoral Ministry from Nazarene Bible College, in Colorado Springs and ...
Breaking Medicine News(10 mins):Health News:B-cell Non-Hodgkin Lymphoma Treatment Market Value worth $5.4 Billion by 2018 Says a New Report Available at MarketOptimizer.org 2Health News:B-cell Non-Hodgkin Lymphoma Treatment Market Value worth $5.4 Billion by 2018 Says a New Report Available at MarketOptimizer.org 3Health News:B-cell Non-Hodgkin Lymphoma Treatment Market Value worth $5.4 Billion by 2018 Says a New Report Available at MarketOptimizer.org 4Health News:Narconon Louisiana Announces New Certifications For Staff 2Health News:Animal Emergency & Referral Center of Minnesota Celebrates National Take Your Cat to the Vet Day 2Health News:Animal Emergency & Referral Center of Minnesota Celebrates National Take Your Cat to the Vet Day 3Health News:Ontraport: Review Exposes Automated Platform for Online Marketing Management 2
... Using a new method, scientists reprogram adult cells to develop ... -- Scientists say they,ve developed a new and easier way ... that can develop into one of many cell types ... this new technique doesn,t use viruses to introduce genes into ...
... use, but other factors may contribute, experts say , MONDAY, ... glaucoma appear to outlive those who don,t treat the eye ... risk for premature death stems from the glaucoma drugs themselves ... to health care remains unclear. , Use of glaucoma drugs ...
... when the regimen is followed, , MONDAY, Feb. 8 (HealthDay ... olive oil, whole grains, fish and fruit -- may protect ... study finds , Other studies have already found that such ... premature death. , The latest study was led by ...
... ... forum for industry professionals, academics, and students to discuss the key issues facing the ... explore the groundbreaking ways in which companies and individuals across every sector of health ... ...
... , , , BOSTON , ... (NPSF) will kick off Patient Safety Awareness Week on ... awareness of patient safety initiatives, improve the quality of health ... providers. , (Logo:   http://www.newscom.com/cgi-bin/prnh/20080307/AQF053LOGO ) , During the ...
... , , ST. PAUL, Minn. , ... more accessible for all Minnesotans – regardless of age or ability ... was introduced into the Minnesota legislature today. The "Complete ... broad coalition of health, family, environment, senior, and transportation advocates who ...
Cached Medicine News:Health News:Stem Cell Research Makes Another Advance 2Health News:Glaucoma Drugs May Play Role in Longer Life 2Health News:Glaucoma Drugs May Play Role in Longer Life 3Health News:Mediterranean Diet May Help Keep You Smarter 2Health News:2010 Wharton Health Care Business Conference - Feb. 25-26, Philadelphia, PA 2Health News:2010 Wharton Health Care Business Conference - Feb. 25-26, Philadelphia, PA 3Health News:National Patient Safety Foundation Leads Nationwide Effort to Promote Patient Safety 2Health News:Broad Coalition Praises Complete Streets Bill Introduced in Minnesota Legislature 2Health News:Broad Coalition Praises Complete Streets Bill Introduced in Minnesota Legislature 3Health News:Broad Coalition Praises Complete Streets Bill Introduced in Minnesota Legislature 4Health News:Broad Coalition Praises Complete Streets Bill Introduced in Minnesota Legislature 5
... Latex based reagent kit to detect Rheumatoid Factor ... the level of RF semi-quantitatively in the human ... includes antigen coated fine latex particles uniformly suspended ... squeezable dropping bottles, re-usable plastic slide, 50 uL ...
RFScan Latex Test Kit-100...
The Array 360 CEAL streamlines processes with computer enhancements and optimizes productivity by offering an exclusive design for aliquot samples....
ELISA kit for detection of Rheumatoid Factor....
Medicine Products: